![Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients—a prospective multicenter study | SpringerLink Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients—a prospective multicenter study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00330-021-07872-3/MediaObjects/330_2021_7872_Fig1_HTML.png)
Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients—a prospective multicenter study | SpringerLink
![Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI? - ScienceDirect Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0899707120300486-gr1.jpg)
Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI? - ScienceDirect
![CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis | Radiology CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2021211244/asset/images/medium/radiol.2021211244.va.gif)
CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis | Radiology
![Frontiers | Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS Frontiers | Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS](https://www.frontiersin.org/files/Articles/641195/fonc-11-641195-HTML-r2/image_m/fonc-11-641195-g001.jpg)
Frontiers | Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
![Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma | Radiology Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2019191086/asset/images/medium/radiol.2019191086.va.gif)
Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma | Radiology
![Figure 2 from Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system | Semantic Scholar Figure 2 from Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/56b1b0aade470106e977091c433424df6b770f10/3-Figure2-1.png)
Figure 2 from Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system | Semantic Scholar
![Frontiers | CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma Frontiers | CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma](https://www.frontiersin.org/files/Articles/897090/fonc-12-897090-HTML/image_m/fonc-12-897090-g001.jpg)
Frontiers | CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
![Identification of the origin of tumor in vein: comparison between CEUS LI- RADS v2017 and v2016 for patients at high risk | BMC Medical Imaging | Full Text Identification of the origin of tumor in vein: comparison between CEUS LI- RADS v2017 and v2016 for patients at high risk | BMC Medical Imaging | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12880-022-00912-4/MediaObjects/12880_2022_912_Fig2_HTML.png)
Identification of the origin of tumor in vein: comparison between CEUS LI- RADS v2017 and v2016 for patients at high risk | BMC Medical Imaging | Full Text
![Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules - ScienceDirect Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827817324285-fx1.jpg)
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules - ScienceDirect
![Frontiers | Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis Frontiers | Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis](https://www.frontiersin.org/files/Articles/873913/fonc-12-873913-HTML/image_m/fonc-12-873913-g002.jpg)